Terlipressin versus other vasoactive drugs for hepatorenal syndrome

BACKGROUND: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal function in people with hepatorenal syndrome, bu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Israelsen, Mads, Krag, Aleksander, Allegretti, Andrew S, Jovani, Manol, Goldin, Alison H, Winter, Rachel W, Gluud, Lise Lotte
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483765/
https://ncbi.nlm.nih.gov/pubmed/28953318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011532.pub2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars